FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35173211000001102: Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Mar 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106510801000001119 Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106510901000001113 Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Has VMP Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Has basis of strength substance Calcipotriol true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Has specific active ingredient Calcipotriol monohydrate true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Has dispensed dose form Foam true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Calcipotriol true Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) 120 gram 2 x 60g Is a True Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam 120 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start